The price you pay for Elevidys may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help you with the ...

The cost of Elevidys can vary based on several factors, including your child’s insurance coverage. Drug savings programs can also lower the price you’ll pay for Elevidys. your child’s ...

Is the Elevidys Market Poised for Significant Growth? .The Elevidys market has experienced substantial expansion, driven by rising cases of Duchenne muscular dystrophy (DMD) and increased ...

New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of motor function in a broad population of individuals with Types 2 or 3 spinal muscular atrophy (SMA) Late-breaking ...

Full-Year Net Product Revenues: $1.8 billion, representing a 56% year-over-year growth. ELEVIDYS Fourth Quarter Sales: $384 million, a 112% increase over the prior sequential quarter. ELEVIDYS ...

We are also very encouraged by the data being shared across our Elevidys studies, affirming the potential of the first gene therapy for the treatment of Duchenne to stabilise or slow disease ...

The successful launch of Elevidys, Sarepta’s gene therapy for DMD, has been a key driver of the company’s recent performance. Following the full-label expansion for Elevidys in DMD patients ...

Net product revenues for the fourth quarter 2024 totaled $638.2 million, a 75% increase over the same quarter of the prior year – ELEVIDYS net product revenue for the quarter totaled $384.2 ...

The successful launch of Elevidys, Sarepta’s gene therapy for DMD, has been a key driver of the company’s recent performance. Following the full-label expansion for Elevidys in DMD patients aged 6 ...